Skip to main content
Free research Free research Free target review with research home and workspace preview
Quick search ChEMBL 36
Loading Target Snapshot...
Querying ChEMBL database. This may take a few seconds.
Target Snapshot

CHEMBL1795153 Target Snapshot

Thymidylate synthase (EC 2.1.1.45) (TS) (TSase) · SINGLE PROTEIN · Escherichia coli

9Compounds
1Assays
1Approved Drugs
9.0Activities
Free Research Context

Research home keeps recent targets

This target will appear in recent viewed items on this browser. Use the demo workspace to preview watch rules and decision queues.

Navigation

Switch target

Move to another high-traffic target or paste a specific ChEMBL target ID.

Broader Open DB context

Frame the target before identity details

Structured disease, protein, and project context should read before the lower-level identity rail.

As of 2026-09-13

Protein identity stays anchored to UniProt E2QDN0. Use UniProt E2QDN0 as the stable identity anchor, then attach disease evidence before program review.

Review focus
Protein anchor ready

Use UniProt E2QDN0 as the stable identity anchor, then attach disease evidence before program review.

ChEMBL component mapping + Open Targets-ready proxy + ChEMBL 36 via Core Engine 2026-09-13
Open source guide
Identity Layer

Cross-source identity

Keep the review anchor, source IDs, and context contract aligned before reusing this target elsewhere.

This review treats Thymidylate synthase (EC 2.1.1.45) (TS) (TSase) as ChEMBL target CHEMBL1795153, mapped to UniProt E2QDN0. Disease framing currently uses the Open Targets-ready proxy contract.

Review anchor
Thymidylate synthase (EC 2.1.1.45) (TS) (TSase)
SINGLE PROTEIN · Escherichia coli
As of 2026-09-13
ChEMBL target ID
CHEMBL1795153
Primary anchor for compounds, assays, approvals, and exports
ChEMBL 36 via Core Engine As of 2026-09-13
www.ebi.ac.uk
UniProt accession
E2QDN0
Thymidylate synthase
UniProt accession via ChEMBL component mapping As of 2026-09-13
www.uniprot.org
Disease evidence contract
Open Targets-ready proxy
ChEMBL drug mechanism + indication proxy
ChEMBL drug mechanism + indication proxy As of 2026-09-13
www.ebi.ac.uk

Reuse the same identifiers in notes, watch rules, exports, and review packs so provenance stays stable across surfaces.

Source Guidance

Start with the right source

Choose the first block or source based on the question you are trying to answer.

Need stable target naming and protein identity?
UniProt Target Context
UniProt accession via ChEMBL component mapping

Start here when your first question is whether Thymidylate synthase (EC 2.1.1.45) (TS) (TSase) is the right protein anchor across sources, using UniProt E2QDN0 as the stable mapping.

Jump to Protein Context
Need disease fit before discussing compounds?
Disease Relevance & Evidence Level
ChEMBL drug mechanism + indication proxy

Use this block first when you need the strongest disease program and evidence level in one place.

Jump to Disease Context
Need a meeting-ready explanation of why this target matters?
Evidence Card
Review-ready rationale with source-aware context

Open the one-page evidence card when you want the rationale, activity base, and attribution together.

Open Review-ready Card
Overview

Basic Information

Verify identity, organism, and the fastest next research jumps from the same page.

UniProt Context

UniProt Target Context

Reviewable protein naming and mapping context for this target snapshot.

Protein LabelThymidylate synthase
UniProt AccessionE2QDN0
Component TypeProtein
Sequence Length367 aa

Thymidylate synthase

Source · UniProt accession via ChEMBL component mapping
Review Cue

How to read this target

Review this target as Thymidylate synthase (EC 2.1.1.45) (TS) (TSase), mapped to UniProt E2QDN0. ChEMBL maps the protein component as Thymidylate synthase. Sequence length is 367 aa.

Mapped IDE2QDN0
Review nameThymidylate synthase (EC 2.1.1.45) (TS) (TSase)
OrganismEscherichia coli
Clinical Profile

Clinical Phase Distribution

1
Approved
1
Phase II
Assay Mix

Activity Type Distribution

IC509.0
Lead Set

Top Inhibitors (by pChEMBL)

ChEMBL IDpChEMBLTypeValue (nM)Phase
CHEMBL1738741 7.77 IC50 17.0 Preclinical
CHEMBL169896 7.64 IC50 23.0 Clinical
CHEMBL389051 7.32 IC50 48.0 Preclinical
CHEMBL1738740 7.3 IC50 50.0 Preclinical
CHEMBL225180 6.68 IC50 210.0 Preclinical
CHEMBL1818548 6.09 IC50 820.0 Preclinical
CHEMBL1818549 6.07 IC50 850.0 Preclinical
CHEMBL225072 4.12 IC50 76000.0 Approved
Distribution

pChEMBL Value Distribution

0
5.0
0
5.5
2
6.0
1
6.5
2
7.0
2
7.5
0
8.0
0
8.5
0
9.0
0
9.5
pChEMBL
Assay Landscape

Assay Landscape

1
Total Assays
8
Tested Compounds
1
Assay Types
Binding — 1 assays, 8 compounds
BAO Format Assays Compounds Avg pChEMBL
single protein format 1 8 6.6

Confidence Score Distribution

Source · ChEMBL 36 via Core Engine